Key regions: China, Europe, Australia, United States, Germany
The pharmaceutical market in Tunisia has been experiencing growth in recent years. Other Pharmaceuticals, which includes products such as vitamins, minerals, and supplements, is a segment of the market that has been particularly active.
Customer preferences: Tunisian consumers are becoming increasingly health-conscious and are more willing to invest in preventative health measures. This has led to a growing demand for Other Pharmaceuticals, as consumers seek to supplement their diets with vitamins and minerals. Additionally, the aging population in Tunisia has also contributed to the growth of this market segment, as older individuals often require additional nutritional support.
Trends in the market: One trend that has been observed in the Other Pharmaceuticals market in Tunisia is the increasing popularity of natural and organic supplements. Consumers are becoming more aware of the potential health benefits of natural products and are willing to pay a premium for them. This has led to a rise in the availability of natural supplements in pharmacies and health food stores across the country.Another trend that has emerged in the market is the growing popularity of online sales channels. E-commerce platforms are becoming increasingly popular in Tunisia, and many consumers are now choosing to purchase their supplements online. This has led to increased competition among online retailers, which has driven down prices and made supplements more accessible to a wider range of consumers.
Local special circumstances: One factor that has contributed to the growth of the Other Pharmaceuticals market in Tunisia is the country's relatively high rate of chronic disease. Conditions such as diabetes, hypertension, and obesity are becoming increasingly prevalent in Tunisia, which has led to a growing demand for supplements that can help manage these conditions.
Underlying macroeconomic factors: Tunisia's economy has been growing steadily in recent years, which has contributed to the growth of the pharmaceutical market as a whole. Additionally, the Tunisian government has been investing in healthcare infrastructure and has implemented policies aimed at improving access to healthcare for all citizens. This has helped to increase demand for pharmaceutical products, including Other Pharmaceuticals.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
